Rosso R - Search Results

1

Resistance to 5-fluorouracil and 5-fluoro-2'-deoxyuridine mechanisms and clinical implications.

Sobrero A, Aschele C, Guglielmi A, Nobile MT, Rosso R. Sobrero A, et al. Among authors: rosso r. J Chemother. 1990 Feb;2 Suppl 1:12-6. doi: 10.1080/1120009x.1990.11738999. J Chemother. 1990. PMID: 2142213

2

Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells.

Sobrero AF, Aschele C, Guglielmi AP, Mori AM, Melioli GG, Rosso R, Bertino JR. Sobrero AF, et al. Among authors: rosso r. J Natl Cancer Inst. 1993 Dec 1;85(23):1937-44. doi: 10.1093/jnci/85.23.1937. J Natl Cancer Inst. 1993. PMID: 8230285

3

Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil.

Mori A, Bertoglio S, Guglielmi A, Aschele C, Bolli E, Tixi L, Rosso R, Sobrero A. Mori A, et al. Among authors: rosso r. Cancer Chemother Pharmacol. 1993;33(2):179-80. doi: 10.1007/BF00685339. Cancer Chemother Pharmacol. 1993. PMID: 8261580

4

In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.

Guglielmi A, Aschele C, Mori A, Baldo C, Russo P, Debernardis D, Valenti M, Bruno S, Taverna M, Rosso R, et al. Guglielmi A, et al. Among authors: rosso r. Clin Cancer Res. 1995 Nov;1(11):1337-44. Clin Cancer Res. 1995. PMID: 9815929

5

Determinants of sensitivity and resistance to fluoropyrimidines.

Aschele C, Guglielmi A, Maioli D, Sobrero A, Rosso R, Nicolin A. Aschele C, et al. Among authors: rosso r. Pharmacol Res. 1990 Sep-Oct;22 Suppl 3:1-2. doi: 10.1016/s1043-6618(09)80001-7. Pharmacol Res. 1990. PMID: 2151469 No abstract available.

6

Current strategies to reduce cisplatin toxicity.

Sobrero A, Guglielmi A, Aschele C, Rosso R. Sobrero A, et al. Among authors: rosso r. J Chemother. 1990 Feb;2(1):3-7. doi: 10.1080/1120009x.1990.11738971. J Chemother. 1990. PMID: 2185345 Review. No abstract available.

7

Comparison of in vitro drug sensitivity by inhibition of tritium release from [5-3H]-2'-deoxyuridine and a clonogenic assay.

Aschele C, Romanini A, Nicolin A, Rosso R, Sobrero A. Aschele C, et al. Among authors: rosso r. Anticancer Res. 1990 May-Jun;10(3):759-64. Anticancer Res. 1990. PMID: 2195987

8

[Cell resistance in oncology. Therapeutic prospects].

Rosso R, Guglielmi A, Aschele C, Mori A, Tixi L, Bolli E, Sobrero A. Rosso R, et al. G Ital Chemioter. 1991 Jan-Dec;38(1-3):95-7. G Ital Chemioter. 1991. PMID: 1365622 Italian. No abstract available.

9

Rapid development of resistance to antifolates in vitro: possible clinical implication.

Sobrero A, Aschele C, Rosso R, Nicolin A, Bertino JR. Sobrero A, et al. Among authors: rosso r. J Natl Cancer Inst. 1991 Jan 2;83(1):24-8. doi: 10.1093/jnci/83.1.24. J Natl Cancer Inst. 1991. PMID: 1824599

10

Sequence-dependent enhancement of HCT-8 cell kill by trimetrexate and fluoropyrimidines: implications for the mechanism of this interaction.

Sobrero A, Romanini A, Russello O, Nicolin A, Rosso R, Bertino JR. Sobrero A, et al. Among authors: rosso r. Eur J Cancer Clin Oncol. 1989 Jun;25(6):977-82. doi: 10.1016/0277-5379(89)90157-0. Eur J Cancer Clin Oncol. 1989. PMID: 2526736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

866 results

Search Page

Filters